Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma

Blood

Volumn 99, Issue 4, 2002, Pages 1405-1410

  Derksen, Patrick W B ^a   Keehnen, Robert M J ^a   Evers, Ludo M ^a   Van Oers, Marinus H J ^a   Spaargaren, Marcel ^a   Pals, Steven T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; PROTEOHEPARAN SULFATE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SYNDECAN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; MULTIPLE MYELOMA; NONHUMAN; ONCOGENE RAS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 0037082492     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.4.1405     Document Type: Article

References (37)

1. Multiple myeloma: Increasing evidence for a multi-step transformation process
2. Regulated diversity of heparan sulfate
3. Functions of cell surface heparan sulfate proteoglycans
4. Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion
5. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation
6. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
7. Proteoglycans and pattern formation: Sugar biochemistry meets developmental genetics
8. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
9. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: Control of tumor cell survival, growth, and bone cell differentiation
10. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1
11. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas
12. Heparan sulfate-mediated cell aggregation: Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells
13. Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells
14. Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins
15. The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation
16. Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines
17. The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma
18. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma
19. Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway
20. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met
21. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo
22. Hepatocyte growth factor and its receptor c-met in multiple myeloma
23. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
24. Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway
25. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
26. High levels of soluble syndecan-1 in myeloma-derived bone marrow: Modulation of hepatocyte growth factor activity
27. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms: Heparan sulfate glycosaminoglycan requirement for Met binding and signaling
28. Syndecan-regulated receptor signaling
29. Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2
30. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
31. Activating mutations for the met tyrosine kinase receptor in human cancer
32. Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis
33. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins
34. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma
35. Regulation of cytokine signaling by B cell antigen receptor and CD40-controlled expression of heparan sulfate proteoglycans
36. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
37. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death